TNF and peripheral nervous system disorder: Previous case series have suggested associations between implementation of anti-TNF-α treatment and onset or progression of peripheral nerve disorders such as Guillain-Barré syndrome, Miller Fisher syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy with conduction block, mononeuropathy multiplex, and axonal sensorimotor polyneuropathies [4].